Alcolase raises EUR 1.5M seed round
The funding will support efficacy trials, regulatory dialogue with Singapore Food Agency, and market entry in Singapore and South Korea.
See the latest news and media coverage for Alcolase. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company developing enzyme delivery technology for alcohol intolerance
alcolase.comLast updated
In short: Alcolase raised €1.5M to fund trials, regulatory dialogue and planned market entry in Singapore and South Korea.
The funding will support efficacy trials, regulatory dialogue with Singapore Food Agency, and market entry in Singapore and South Korea.
Henrik brings extensive scientific experience and will lead Alcolase's product development towards market readiness. He is excited to expand research and collaborations.
Ib Christensen shares his role, motivations, and vision for Alcolase's future, highlighting key experiences and goals for product commercialization and collaborations.
Mikkel Precht shares his role, motivations, and hopes for Alcolase's future, including user trials and social choice empowerment.
While Alcolase is aming to commercialize its enzyme system globally, its strategic focus lies in East Asia -- home to an estimated 500 million alcohol-intolerant...
MEET OUR Resident Alcolase On a mission to make drinking alcohol a healthier experience for everyone. Consuming alcohol is a...
MEET OUR RESIDENT Alcolase On a mission to make drinking alcohol a healthier experience for everyone Consuming alcohol is a part of celebratory traditions all...
A group of entrepreneurs is working on developing a solution for the 30-50 percent of the population in China, Japan, Taiwan and Korea,...
Track Alcolase and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.